omeprazole has been researched along with Chronic Lung Injury in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"Omeprazole was administered either (1) directly to the fetus, (2) to the mother or (3) after birth to the pups in different doses (2-10 or 20 mg/kg)." | 5.43 | Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury. ( Brady, P; Deprest, J; Jimenez, J; Lesage, F; Nagatomo, T; Richter, J; Salaets, T; Toelen, J; Vanoirbeek, J, 2016) |
"Omeprazole was administered either (1) directly to the fetus, (2) to the mother or (3) after birth to the pups in different doses (2-10 or 20 mg/kg)." | 1.43 | Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury. ( Brady, P; Deprest, J; Jimenez, J; Lesage, F; Nagatomo, T; Richter, J; Salaets, T; Toelen, J; Vanoirbeek, J, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Richter, J | 1 |
Jimenez, J | 1 |
Nagatomo, T | 1 |
Toelen, J | 1 |
Brady, P | 1 |
Salaets, T | 1 |
Lesage, F | 1 |
Vanoirbeek, J | 1 |
Deprest, J | 1 |
Shivanna, B | 1 |
Chu, C | 1 |
Welty, SE | 1 |
Jiang, W | 1 |
Wang, L | 1 |
Couroucli, XI | 1 |
Moorthy, B | 1 |
2 other studies available for omeprazole and Chronic Lung Injury
Article | Year |
---|---|
Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury.
Topics: Animals; Animals, Newborn; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Down-Regulatio | 2016 |
Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor.
Topics: Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Chemokine CCL2; Cytoprotection; Epithelia | 2011 |